All News from Accelerate Diagnostics

All News

Recent symposia and study data add evidence of improved patient outcomes

Jul 23, 2021 — Despite being held virtually, the World Microbe Forum (WMF) and 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) succeeded in bringing together experts across the clinical microbiology and infectious diseases specialties to share their latest findings following the unprecedented demand for their expertise to address the ongoing COVID-19 pandemic. Recent symposia and study […]

Continue reading ›

New Accelerate Pheno® Landmark Study Validates Important Clinical Benefits to Be Presented at ECCMID 2021

Jun 30, 2021 — In Patients Who Receive Ineffective Empirical Antibiotics for Blood Stream Infections (BSI), Use of AXDX Was Associated With Reduction in 30-Day Mortality Interim Data From Multicenter Study Highlight the Real-World Clinical Utility of Fast Phenotypic Antimicrobial Susceptibility Testing for BSI Across Diverse Healthcare Settings and Patient Populations Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced that it […]

Continue reading ›

Accelerate Diagnostics Receives CARB-X Award to Develop Rapid Optical Imaging Technology for Sepsis and Antibiotic-Resistant Infections

Jun 08, 2021 — CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator), a global non-profit partnership dedicated to accelerating research and development to address the rising global threat of drug-resistant bacteria, has awarded Accelerate Diagnostics up to $578,000 to develop new fiber optic technology to diagnose sepsis or the risk of sepsis. Accelerate would be eligible for up to $2.1 million […]

Continue reading ›

KFVS12 Covers SoutheastHEALTH’s Adoption of Accelerate Pheno System
KFVS12 Covers SoutheastHEALTH’s Adoption of Accelerate Pheno System

Jun 02, 2021 — Jessica Ladd of the CBS affiliate station in Cape Girardeau, MO, covered SoutheastHEALTH’s implementation of the Accelerate Pheno system for fast diagnosis of bloodstream infections. Read the article here.

Continue reading ›

New Multi-Center Accelerate Pheno® Study: Significant Improvements in Multiple Outcomes for Gram-Positive Bloodstream Infections

May 22, 2021 — A new, multicenter study published today in the Journal of Antimicrobial Chemotherapy shows that use of the Accelerate Pheno system for identification and antimicrobial susceptibility testing of Gram-positive bloodstream infections supports improvements in multiple important clinical outcomes, including: Reduction in time to optimal therapy (TTOT) of 15.9 hours Reduction in time to first antibiotic modification […]

Continue reading ›

Accelerate Diagnostics Reports First Quarter 2021 Financial Results

May 06, 2021 — Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the first quarter for the period ended March 31, 2021. “First quarter financial results were consistent with our expectations,” commented Jack Phillips, Chief Executive Officer of Accelerate Diagnostics, Inc. “We also progressed key commercial and product development programs during the quarter.” For highlights and additional […]

Continue reading ›

First Quarter 2021 Earnings Results Conference Call

May 04, 2021 — Accelerate Diagnostics First Quarter 2021 Earnings Results Conference Call will take place on Thursday, May 6 at 4:30pm EDT. To listen by phone, dial +1.877.883.0383 and enter the conference ID: 4747452 International participants may dial +1.412.902.6506. Please dial in 10-15 minutes prior to the start of the conference. A webcast will be available at https://services.choruscall.com/mediaframe/webcast.html?webcastid=CFRMfBFN. […]

Continue reading ›

Accelerate Pheno<sup>®</sup> System Live at Midland Memorial Hospital
Accelerate Pheno® System Live at Midland Memorial Hospital

Apr 22, 2021 — Today, Midland Memorial Hospital in Midland, Texas announced that its laboratory team took the Accelerate Pheno® system clinically live to improve care for patients with bloodstream infections and sepsis. The system will enable the laboratory’s microbiology team to deliver fast antimicrobial susceptibility results with minimum inhibitory concentrations to clinicians who serve Midland Memorial’s patients. Midland […]

Continue reading ›

Albany Medical Center Study Finds Accelerate Pheno System Helps Improve Sepsis and Mortality Outcomes

Apr 08, 2021 — A new study published in Antimicrobial Agents and Chemotherapy found that implementing the Accelerate Pheno® system helped Albany Medical Center Hospital significantly improve laboratory workflow and multiple clinical outcomes for patients with Gram-negative bacteremia. The institution found post-implementation improvements in time to susceptibility results, antibiotic exposure, risk of 30-day mortality, and sepsis resolution. The complete […]

Continue reading ›

New Allegheny Health Study Shows Accelerate Pheno<sup>®</sup> System Helps Improve Multiple Clinical Outcomes
New Allegheny Health Study Shows Accelerate Pheno® System Helps Improve Multiple Clinical Outcomes

Mar 05, 2021 — A new study published in Infection by Allegheny Health Network shows that use of the Accelerate Pheno® system has enabled the institution to significantly improve multiple clinical outcomes for patients with Gram-negative bloodstream infections. The study authors, which included the Allegheny Health antimicrobial stewardship team led by Thomas L. Walsh, MD, found that using the […]

Continue reading ›